Survivorship | Children with Cancer UK

Filter by Cancer Type

Developing targeted CAR T-cell therapy for hard-to-treat Acute Myeloid Leukaemia

Identification of novel surface antigen targets for CAR T-cell strategies in paediatric Acute Myeloid Leukaemia stem cells

Dr Macarena Oporto Espuelas, UCL Great Ormond Street Institute of Child Health

Developing 3-dimensional multicellular models of osteosarcoma

Developing 3-dimensional multicellular models of osteosarcoma

Dr Claire Clarkin (wearing red coat), University of Southampton

How do genes drive the growth and spread of osteosarcoma?

Developmental states of localised and metastatic osteosarcoma cells – a knowledge bank for novel biomarkers and therapeutic approaches

Dr Sam Behjati, Wellcome Sanger Institute

Studying the risk of side effects in childhood cancer survivors

Risk stratification of the national population of survivors of childhood, teenage and young adult cancer for evidence-based clinical follow-up

Professor Michael Hawkins, Centre for Childhood Cancer Survivor Studies, University of Birmingham

Immunotherapy for relapsed paediatric acute lymphoblastic leukaemia

Immunotherapy for relapsed paediatric acute lymphoblastic leukaemia

Professor Persis Amrolia, UCL Institute of Child Health, London

Reducing toxicity in treatment for children with high-risk neuroblastoma

Combinatorial targeting of Anaplastic Lymphoma Kinase (ALK) for neuroblastoma immunotherapy

Professor John Anderson, Institute of Child Health, University College London

1 2 3 4 5 6